Recombinant human HSP60 produced in ClearColi™ BL21(DE3) does not activate the NFκB pathway.
about
Enterotoxigenic Escherichia coli Flagellin Inhibits TNF-Induced NF-κB Activation in Intestinal Epithelial Cells.Effect of alginate microencapsulation on the catalytic efficiency and in vitro enzyme-prodrug therapeutic efficacy of cytosine deaminase and of recombinant E. coli expressing cytosine deaminase.A Mycobacterium avium subsp. paratuberculosis relA deletion mutant and a 35 kDa major membrane protein elicit development of cytotoxic T lymphocytes with ability to kill intracellular bacteria.
P2860
Recombinant human HSP60 produced in ClearColi™ BL21(DE3) does not activate the NFκB pathway.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年学术文章
@wuu
2015年学术文章
@zh-cn
2015年学术文章
@zh-hans
2015年学术文章
@zh-my
2015年学术文章
@zh-sg
2015年學術文章
@yue
2015年學術文章
@zh
2015年學術文章
@zh-hant
name
Recombinant human HSP60 produc ...... not activate the NFκB pathway.
@en
type
label
Recombinant human HSP60 produc ...... not activate the NFκB pathway.
@en
prefLabel
Recombinant human HSP60 produc ...... not activate the NFκB pathway.
@en
P2093
P1433
P1476
Recombinant human HSP60 produc ...... not activate the NFκB pathway.
@en
P2093
Christine Robert-Da Silva
Cynthia Planesse
Thomas Iwema
Wildriss Viranaïcken
P304
P356
10.1016/J.CYTO.2015.01.028
P577
2015-03-12T00:00:00Z